1 |
Expression of ER/PR Receptor, Her-2/neu, Ki67 and p53 in Endometrial Carcinoma: Clinicopathological Implication and Prognostic Value |
|
| | V. B. Shivkumar,Manisha A. Atram,Nitin M. Gangane | | | Indian Journal of Gynecologic Oncology. 2020; 18(3) | | | [Pubmed] [Google Scholar] [DOI] | | 2 |
Immunohistochemical study of ER, PR, p53 and Ki67 expression in patients with endometrial adenocarcinoma and atypical endometrial hyperplasia |
|
| | Rachana Lakhe,Ravi M Swami,Preeti Doshi,Manjiri N Karandikar,Ravindra Nimbargi | | | IP Archives of Cytology and Histopathology Research. 2020; 5(4): 274 | | | [Pubmed] [Google Scholar] [DOI] | | 3 |
Hormonal receptor expression in endometrial carcinoma: A retrospective immunohistochemical study in a Nigerian tertiary hospital |
|
| | SegunSamson Odetola, MustaphaAkanji Ajani, Oluwadamilare Iyapo, AyodejiA Salami, ClementAbu Okolo | | | Journal of West African College of Surgeons. 2020; 10(2): 1 | | | [Pubmed] [Google Scholar] [DOI] | |
|